Sprifermin
- Generic Name
- Sprifermin
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 890058-52-3
- Unique Ingredient Identifier
- UEJ4E476ZP
- Background
Sprifermin has been used in trials studying the treatment of Osteoarthritis, Knee and Cartilage Injury of Knee.
- Associated Conditions
- -
- Associated Therapies
- -
Menopause and Osteoarthritis: Any Association
Osteoarthritis (OA) is a disabling joint disease affecting over 100 million globally, with higher prevalence in women post-menopause. Estrogen deficiency may increase OA risk. Current treatments focus on symptom relief, but there's a need for effective, safe new therapies. Research is exploring new drugs and regenerative therapies for better outcomes.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath